Month: April 2022

Not for distribution to U.S. news wire services or for dissemination in the United States TORONTO-Ontario, April 29, 2022 (GLOBE NEWSWIRE) — Avante Logixx Inc. (TSX.V: XX) (OTC: ALXXF) (“Avante” or the “Company”) announces today that it is calling a special meeting of shareholders of the Company to be held virtually on Monday, May 30, 2022 at 10:00 a.m. (Toronto time) (the “Meeting”). The Meeting will be held to consider and, if thought advisable, to pass, with or without variation, in accordance with the requirements of Policy 5.3 – Acquisitions and Dispositions of Non-Cash Assets of the TSX Venture Exchange, an ordinary resolution concerning the sale of all of the issued and outstanding common shares of the Company’s wholly-owned subsidiary, Logixx Security Inc., to SSC Security Services Corp. (“SSC”) in consideration for...

IDEX Biometrics’ 2021 executive remuneration report is enclosed (link below). The file is also available at the company’s web site www.idexbiometrics.com. For further information contact:Marianne Bøe, Head of Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: +47 918 00186 About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal touch-free authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices, or gain admittance to buildings with the touch of a finger. We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity. For more information,...

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and Indianapolis, US – 29 April 2022, 23:00 CEST: Acacia Pharma Group plc (“Acacia Pharma”, the “Group” or the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures or cancer chemotherapy, announces the publication of its Annual Report and Financial Statements for the Year ended 31 December 2021.  The Annual Report is attached below and also available on www.acaciapharma.com in the Investors/Financial Reports and Presentations section. ContactsAcacia Pharma Group plcMike Bolinder, CEO+44 1223 919760 / +1 317...

SHANGHAI, China, April 29, 2022 (GLOBE NEWSWIRE) — Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) (“Baozun” or the “Company”), the leading brand e-commerce service partner that helps brands execute their e-commerce strategies in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2021 with the U.S. Securities and Exchange Commission (“SEC”) on April 29, 2022. The annual report can be accessed on the Company’s investor relations website at http://ir.baozun.com as well as the SEC’s website at http://www.sec.gov. The Company will provide a hard copy of its annual report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. Requests should be directed to the Company’s...

HOUSTON, April 29, 2022 (GLOBE NEWSWIRE) — NCS Multistage Holdings, Inc. (“NCS” or the “Company”) (NASDAQ:NCSM) will host a conference call to discuss its first quarter 2022 results on Friday, May 6, 2022 at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). NCS will issue its first quarter 2022 earnings release the evening prior to the conference call. To join the conference call from within the United States, participants may dial (866) 374-5140. To join the conference call from outside of the United States, participants may dial (404) 400-0571. The conference access code is 40658981#. Participants are encouraged to log in to the webcast or dial in to the conference call approximately ten minutes prior to the start time. To listen via live webcast, please visit the Investors section of the Company’s website, www.ncsmultistage.com. The...